PENN Company Profile

The Blank Checks company announced Sales of $3.452357 millions, in the October to December 31 2022

ZING disclosed $3.452357 millions, in Sales in the fourth quarter of 2022.

Losses Cut on Soft Sales at the company in the fourth quarter of 2022

For the most recent fiscal period Eiger Biopharmaceuticals Inc managed to slice its losses on diminishing revenue, where deficit per share were at $-0.46 compared to $-0.64 and revenue decreased by -19.762 % to $2.70 millions in contrast to $3.36 millions in the same financial reporting period a year ago.

For the fourth quarter of 2022 company had turn a round to income by presenting EPS of $1.89 per share compare to $-0.64 a year ago and earnings per share turned positive from $-2.11 per share from the prior quarter.

Sales remained unscathed to $0.00 millions from $3.36 millions in the corresponding quarter a year ago and sequentially Sales Tumbled from $0.00 millions.

Very stunning 54.111%, jump in Sales at Federal Home Loan Bank Of Boston all along the fiscal span closing Dec 31 2022

For the most recent fiscal period Federal Home Loan Bank Of Boston reached zero gain of $0.00 per share compare to $0.00 a year prior and from $0.00 per share from the previous reporting period.

Sales inched up strongly by 54.111 % to $75.28 millions from $48.85 millions in the corresponding reporting period a year prior and sequentially Sales deteriorated by -13.874 % from $87.41 millions.

ABEV has achieved Bottom and Top-line advance for the October to December 31 2022. Sales were at $15.14 billions increased by 9.409 % year on year and deteriorated by 0 % quarter on quarter, while income per share grew by 14.17 % to $0.17, sequentially by 0 %.